The present invention provides a method of inhibiting Fyn/Lck fatty acylation and protein palmitoylation in a cell in an individual in need of such treatment comprising the step of administering to said individual a pharmacologically effective dose of 2-bromopalmitate. Also provided is a method of treating an individual having an autoimmune disease comprising the step of administering to said individual a pharmacologically effective dose of 2-bromopalmitate.
CROSS REFERENCE TO RELATED APPLICATION
This is a 371 of PCT/US00/26190 filed Sep. 22, 2000 and claims benefit of priority of U.S. Provisional Application No. 60/155,743, filed Sep. 23, 1999, now abandoned.
